Navigating the evolving treatment landscape in mTNBC: What are the key considerations for clinical practice today?

touchIN CONVERSATION for touchONCOLOGY   Listen to two breast cancer experts, Prof. Peter Schmid and Dr Marleen Kok discuss the mechanisms of action and latest data for  emerging treatment options and how they are changing the management of metastatic triple negative breast cancer (mTNBC). The discussion is guided by pre-canvassed questions from the breast cancer clinical community. This touchPODCAST is for HCPs only.  This activity is funded by an unrestricted independent medical education grant from Gilead and is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/evolving-treatment-landscape-in-mtnbc/